Eli Lilly and Company (LLY)
XETR
Closed
Aug 24, 2026
Day's Range
1,056.0052 wk Range
596.30Profile - LLY - Eli Lilly and Company
Profile
Mic Code
XETR
Sector
Healthcare
Industry
Drug Manufacturers - General
Employees
50K
Eli Lilly and Company is a global pharmaceutical company focused on discovering, developing, manufacturing, and marketing prescription medicines for human health. Headquartered in Indianapolis, Indiana, and founded in 1876, the company operates in therapeutic areas that include diabetes, obesity, oncology, immunology, neuroscience, and other specialty conditions. Eli Lilly and Company’s portfolio features innovative treatments for metabolic diseases, cancer, autoimmune disorders, and neurological conditions, supported by a broad pipeline of biologics, small molecules, and next-generation therapies. The company conducts research and clinical development across multiple geographies and manufactures medicines through facilities in the United States, Puerto Rico, Europe, and Asia, distributing its products in around 90 countries. Eli Lilly and Company plays a significant role in the healthcare system by working with physicians, hospitals, payers, and governments to make its therapies available to patients worldwide, while maintaining a single core business segment centered on human pharmaceutical products.
Profile Details
Type
Common Stock
Ceo
Mr. David A. Ricks
Address
Lilly Corporate Center
City
Indianapolis
State
IN
Zip
46285
Country
United States
Phone
317 276 2000
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
